On January 31, 2022, Ronald W. Barrett, Independent Director notified Concert Pharmaceuticals, Inc. that he will not stand for re-election at the company's 2022 Annual Meeting of Stockholders. Dr. Barrett's decision to not stand for re-election was personal and not related to any disagreement with the company on any matter relating to its operations, policies or practices.
Concert Pharmaceuticals, Inc.
Equities
CNCE
US2060221056
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+49.21% | 56.87B | |
+36.22% | 39.72B | |
-6.86% | 39.27B | |
-4.42% | 28.73B | |
+12.00% | 26.21B | |
-18.27% | 19.79B | |
+29.57% | 12.28B | |
+25.41% | 12.23B | |
-0.35% | 12.12B |